Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 79

Results For "MD"

1112 News Found

Nanavati-Max Hospital, Mumbai to expand capacity by over 600 beds
Hospitals | May 09, 2022

Nanavati-Max Hospital, Mumbai to expand capacity by over 600 beds

The new building is expected to be commissioned by 2024. Post the expansion, Nanavati-Max Hospital will be amongst the largest private sector hospital in western India


Oncocyte completes validation of Therasure transplant monitor test
Biotech | May 08, 2022

Oncocyte completes validation of Therasure transplant monitor test

Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions


USFDA clears Abbott’s test to detect four sexually transmitted infections simultaneously
Drug Approval | May 06, 2022

USFDA clears Abbott’s test to detect four sexually transmitted infections simultaneously

Abbott's multiplex test runs on its most advanced molecular PCR platform, the Alinity m system, which provides fast results in high volumes – detecting four infections simultaneously


Mediso acquires nuclear medicine supplier Bartec Technologies
Biotech | May 05, 2022

Mediso acquires nuclear medicine supplier Bartec Technologies

In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership


Mylab launches RT-PCR test for Ankylosing Spondylitis ahead of the World AS Day
Medical Device | May 04, 2022

Mylab launches RT-PCR test for Ankylosing Spondylitis ahead of the World AS Day

This RT-PCR diagnostic kit helps in diagnosis of AS by detecting HLAB27 gene


Sage Therapeutics and Biogen initiate rolling submission of New Drug Application for Zuranolone
Biotech | May 02, 2022

Sage Therapeutics and Biogen initiate rolling submission of New Drug Application for Zuranolone

The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023


Xcardia announces first-in-human use of its new Xtractor device
Biotech | May 02, 2022

Xcardia announces first-in-human use of its new Xtractor device

The announcement follows FDA 510(k) clearance of device


Physicians foresee an Alzheimer's Disease treatment revolution supported by advanced testing tools
Biotech | May 02, 2022

Physicians foresee an Alzheimer's Disease treatment revolution supported by advanced testing tools

Blood test for early detection of Alzheimer's Disease (AD) risk will lead to better patient care, physicians say; US. adults call for earlier evaluation and more education


Ultomiris approved in the US for adults with generalised myasthenia gravis
Drug Approval | April 29, 2022

Ultomiris approved in the US for adults with generalised myasthenia gravis

Ultomiris showed early effect and lasting improvement in activities of daily living and has potential to reduce treatment burden with dosing every 8 weeks


Lilly's tirzepatide delivered up to 22.5% weight loss in adults with obesity
Biotech | April 29, 2022

Lilly's tirzepatide delivered up to 22.5% weight loss in adults with obesity

Participants taking tirzepatide lost up to 52 lb. (24 kg) in this 72-week phase 3 study